Pharmacological MRI allows the visualization of brain pharmacological effects of drugs using fMRI. In order to clarify the relationship between fMRI signal and receptor occupancy or behavioral response, we performed [11C]-raclopride PET, fMRI and the behavioral assessment with raclopride, dopamine D2 receptor antagonist. The positive fMRI response and cataleptic behavior were observed at the dose of raclopride showing 83% of D2 receptor occupancy, but not at the dose of raclopride showing 42% of D2 receptor occupancy. These results suggest that fMRI and behavioral response induced by raclopride will be needed the high D2 receptor occupancy.
This abstract and the presentation materials are available to members only; a login is required.